Disease-specific survival as regards the uterine sarcoma with age, menopausal status and blood types. A. The survival rate with six age range (40 and below, 41-50, 51-60, 61-70, 71-80, 81 and above); B. The survival rate with pre- and post-menopausal patients; C. Compare the patient number with four blood types (A, B, O, AB) biannually for five years (left); The survival rate with four blood types (right).